AtonRa Partners’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $428K | Sell |
16,808
-2,364
| -12% | -$60.2K | 0.85% | 48 |
|
|
2023
Q3 | $266K | Sell |
19,172
-2,775
| -13% | -$38.6K | 0.56% | 87 |
|
|
2023
Q2 | $505K | Sell |
21,947
-1,832
| -8% | -$42.1K | 0.78% | 56 |
|
|
2023
Q1 | $705K | Sell |
23,779
-3,346
| -12% | -$99.1K | 1.03% | 30 |
|
|
2022
Q4 | $677K | Sell |
27,125
-7,337
| -21% | -$183K | 0.86% | 50 |
|
|
2022
Q3 | $750K | Sell |
34,462
-134
| -0.4% | -$2.92K | 0.74% | 61 |
|
|
2022
Q2 | $681K | Sell |
34,596
-17,368
| -33% | -$342K | 0.63% | 74 |
|
|
2022
Q1 | $2.2M | Buy |
51,964
+4,235
| +9% | +$179K | 1.19% | 31 |
|
|
2021
Q4 | $3.03M | Buy |
47,729
+17,641
| +59% | +$1.12M | 1.05% | 37 |
|
|
2021
Q3 | $1.77M | Buy |
30,088
+3,130
| +12% | +$184K | 0.59% | 68 |
|
|
2021
Q2 | $1.31M | Buy |
+26,958
| New | +$1.31M | 0.48% | 76 |
|